GLP-1 Agonists Enter the Conversation on Psoriatic Disease
GLP-1 agonists are reframing cardiometabolic risk management in psoriatic disease, giving dermatologists a direct tool against the comorbidities they see at every visit.
Topic
Metabolic Syndrome
Topic
Metabolic Syndrome
GLP-1 Drugs May Ease Psoriasis in Some Patients, Study Finds
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and…
GLP-1 Combination Therapy Signals New Benefits in Psoriasis
NewsNation reports GLP-1 combination therapy may unlock new benefits for psoriasis patients, extending the metabolic-skin overlap…
GLP-1 Drugs and Psoriasis: What the Evidence Actually Shows
GLP-1 receptor agonists are drawing attention as potential psoriasis therapy, but the evidence so far is observational and mechan…